Dr. Nezam H. Afdhal joins Spring Bank Pharmaceuticals boards
Spring Bank Pharmaceuticals has named Nezam H. Afdhal, M.D. chair of the clinical advisory board and member of the scientific advisory board. Dr. Afdhal is recognized in the treatment and development of new antiviral therapies of hepatitis.
Dr. Afdhal is currently chief of hepatology and director of the Liver Center at Beth Israel Deaconess Medical Center, and associate professor of medicine at Harvard Medical School.